Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New modulators of adenosine receptors identified at Bayer

Nov. 12, 2002

Angiogenix demonstrates angiogenic activity in preclinical trials

Nov. 8, 2002

Remodulin approved for pulmonary arterial hypertension in Israel

Nov. 7, 2002

Exelixis and GSK to form alliance in vascular biology, inflammatory disease and oncology

Nov. 6, 2002

Novartis acquires rights to AGE breaker from Torrent

Nov. 5, 2002

Chemokine CCR2 and/or CCR3 antagonists under study at Pfizer

Nov. 5, 2002

Sales of WorldHeart's Novacor LVAS continue to rise

Nov. 4, 2002

Bayer researchers present novel activators of guanylate cyclase

Nov. 4, 2002

Telik and Sanwa describe new MCP-1 antagonists with potential in asthma and other disorders

Nov. 4, 2002

Factor 5A gene is expressed in human heart tissue

Nov. 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy
BioWorld
Eli Lilly and Co. plans to buy Centessa Pharmaceuticals plc for $6.3 billion in up-front cash and another potential $1.5 billion through contingent value rights,...